On October 20th, Baekje announced that the National Institute of Health and Clinical Optimization (NICE) in the UK has released a final evaluation document recommending the company's product, Baekje& ...

Lilly Pharmaceuticals claims that its treatment for lymphocytic leukemia, Jaypirca (pirobrutinib/pirobrutinib), has been approved by the US Food and Drug Administration (FDA).